Vistra Corp (VST)
Vistra vs. Talen: Which Stock Is Better Positioned for Investors?
VST's nuclear scale, diversified generation mix, lower debt-to-capital ratio and stronger ROE give it an edge over TLN.
Vistra: Q2 2026 Confirmed The AI Power Scarcity Problem
I maintain my Strong Buy rating and $220 price target on Vistra Corp., with Q2 2026 results strengthening my conviction. VST's diversified generation assets and integration in PJM/ERCOT position it to capitalize on AI-driven electricity scarcity and accelerating data center demand. Helix digital infrastructure offers new upside optionality, but I await signed contracts before factoring material value into my valuation.
Wall Street Analysts See Vistra (VST) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Vistra Corp. (VST) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Vistra Corp. (VST) closed at $140.73, marking a -5.16% move from the previous day.
Vistra's Price Has Edged Downward Throught 2026: One Analyst Says It's Due to Double Soon.
Vistra has quietly shed a quarter of its value while its operating results kept beating expectations, and Wall Street's most bullish analyst thinks that disconnect points to something big coming in 2027.
VST Stock Outperforms Industry in the Past 3 Months: Time to Buy?
Vistra's hedging, long-term PPAs, diversified generation fleet and improving earnings outlook support growth, though high debt may warrant a better entry point.
Vistra: Cogentrix And Meta Can Offset A Softer ERCOT Outlook
Vistra (VST) remains a Buy, offering diversified power generation, robust profitability, and resilience amid evolving power market fundamentals. Q2 adjusted EBITDA surged over 30%, driven by strong Texas and PJM generation, with management guiding 2026 results at or above midpoint. Cogentrix acquisition and Meta contracts are expected to offset ERCOT weakness, though the deal increases leverage and dilutes recent share buybacks.
Beyond Meta and Nuclear: Inside Vistra's Real Power Play
Vistra just signed 20-year nuclear deals with Meta and AWS, acquired thousands of megawatts of gas generation, and committed a billion dollars to an AI venture with NVIDIA and KKR.
Vistra Is Down, But The Growth Narrative Just Got Stronger
Vistra is rated Buy at $152, reflecting improved risk/reward after a 12% pullback, higher EBITDA, and a stronger outlook. Electricity demand growth, especially in ERCOT and PJM, underpins VST's value, with data centers, electrification, and industrial activity as key drivers. Existing gas and nuclear assets, long-term contracts with Meta and AWS, and the Cogentrix acquisition enhance VST's earnings visibility and strategic positioning.
Vistra: Set For A Guidance Boost, Exposing Its Undervaluation
Vistra Corp. (VST) is positioned for significant upside, with a fair value estimate of $231 per share, implying 60% upside. VST's diversified generation fleet, strong data center demand, and strategic deals (Cogentrix, META, Helix) underpin robust long-term EBITDA growth. Despite recent ERCOT pricing headwinds, I expect 2027 EBITDA guidance to rise, driven by $700 million incremental EBITDA from acquisitions and the META deal.
Can VST's Diversified Power Generation Fleet Drive Long-Term Growth?
Vistra's diversified 43,641-MW fleet lowers dependence on a single fuel source and positions it to benefit from rising U.S. electricity demand.
Vistra: AI Power Provider Meets Load Growth & Acquisition Upside - Reiterate Buy
Moratoriums introduce regulatory uncertainty and potential project delays, but VST's robust PPA pipelines and colocation strategy with existing assets mitigate risks. The diversified ERCOT/PJM assets and AI partnerships like Helix Digital Infrastructure position it to capitalize on the multi-year data center power demand. VST expects a rich FY2027 adj EBITDA of $7.6B–$8.3B (with upside from Cogentrix and META PPAs), while maintaining a healthy balance sheet at a ratio of ~2.3x.
